Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death–Ligand 1 Interaction as Potential Anticancer AgentsBinbin Cheng, Jianjun Chen, Deying Yang et al.|Journal of Medicinal Chemistry|2020Cited by 85
Discovery of Novel and Highly Potent Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer TreatmentBinbin Cheng, Shuanghu Wang, Yingfeng Tu et al.|Journal of Medicinal Chemistry|2020Cited by 51
Drug Repurposing of Itraconazole and Estradiol Benzoate against COVID‐19 by Blocking SARS‐CoV‐2 Spike Protein‐Mediated Membrane FusionChan Yang, Wei Xü, Yihong Wan et al.|Advanced Therapeutics|2021Cited by 36
Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammationWei Wang, Shuwen Liu, Shasha Li et al.|Acta Pharmacologica Sinica|2021Cited by 36
CPI‐203 improves the efficacy of anti‐PD‐1 therapy by inhibiting the induced PD‐L1 overexpression in liver cancerXiaoge Niu, Shuwen Liu, Wei Wang et al.|Cancer Science|2021Cited by 9